The association of liver enzymes with biomarkers of subclinical myocardial damage and structural heart disease.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Hepatology

• Publication date

  2015-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jhep.2014.11.024PMID 25433159PMCID PMC4373587
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

  2013cited by this paper
• 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.

  2013cited by this paper
• NH2-Terminal Pro–Brain Natriuretic Peptide and Risk of Diabetes

  2013cited by this paper
• Liver enzymes, race, gender and diabetes risk: the Atherosclerosis Risk in Communities (ARIC) Study

  2013cited by this paper
• Obstructive Sleep Apnea–Hypopnea Syndrome and Nonalcoholic Fatty Liver Disease: Emerging Evidence and Mechanisms

  2012cited by this paper
• NPs -- heart hormones that regulate brown fat?

  2012cited by this paper
• A survey of patterns of practice and perception of NAFLD in a large sample of practicing gastroenterologists in France.

  2012cited by this paper
• The inverse relationship between alanine aminotransferase in the normal range and adverse cardiovascular and non-cardiovascular outcomes.

  2011cited by this paper
• Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.

  2011cited by this paper
• Cardiac Troponin T Measured by a Highly Sensitive Assay Predicts Coronary Heart Disease, Heart Failure, and Mortality in the Atherosclerosis Risk in Communities Study

  2011cited by this paper
• Sources of variability in measurements of cardiac troponin T in a community-based sample: the atherosclerosis risk in communities study.

  2011cited by this paper
• Ectopic Fat Depots and Cardiovascular Disease

  2011cited by this paper
• The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis

  2010cited by this paper
• Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease

  2010cited by this paper
• Population-based risk factors and resource utilization for HCC: US perspective

  2010cited by this paper
• Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population.

  2010cited by this paper
• Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: A narrative review and clinical perspective of prospective data

  2010cited by this paper
• Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease.

  2010cited by this paper
• Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults.

  2010cited by this paper
• Relationship of hepatic steatosis and alanine aminotransferase with coronary calcification

  2010cited by this paper
• A sensitive cardiac troponin T assay in stable coronary artery disease.

  2009cited by this paper
• Natriuretic Peptides/cGMP/cGMP-Dependent Protein Kinase Cascades Promote Muscle Mitochondrial Biogenesis and Prevent Obesity

  2009cited by this paper
• Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population.

  2009cited by this paper
• Use of multiple biomarkers to improve the prediction of death from cardiovascular causes.

  2008cited by this paper
• Is liver fat detrimental to vessels?: intersections in the pathogenesis of NAFLD and atherosclerosis.

  2008cited by this paper
• Brief Communication: Clinical Implications of Short-Term Variability in Liver Function Test Results

  2008cited by this paper
• Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?

  2008cited by this paper
• The epidemiology of nonalcoholic fatty liver disease: a global perspective.

  2008cited by this paper
• Control of lipolysis by natriuretic peptides and cyclic GMP.

  2008cited by this paper
• Amino-terminal pro-B-type natriuretic peptides: testing in general populations.

  2008cited by this paper
• Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review.

  2008cited by this paper
• Mechanisms of disease progression in nonalcoholic fatty liver disease.

  2008cited by this paper
• Cardiac Steatosis in Diabetes Mellitus: A 1H-Magnetic Resonance Spectroscopy Study

  2007cited by this paper
• Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: an open question.

  2007cited by this paper
• N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease.

  2007cited by this paper
• Hepatic steatosis is associated with a greater prevalence of coronary artery calcification in asymptomatic men.

  2007cited by this paper
• Gamma-Glutamyltransferase Is Associated With Incident Vascular Events Independently of Alcohol Intake: Analysis of the British Women’s Heart and Health Study and Meta-Analysis

  2007cited by this paper
• Adiposity of the Heart*, Revisited

  2006cited by this paper
• Amino-Terminal Pro-B-Type Natriuretic Peptide and B-Type Natriuretic Peptide: Biomarkers for Mortality in a Large Community-Based Cohort Free of Heart Failure

  2006cited by this paper
• Non‐cardiac determinants of NT‐proBNP levels in the elderly: Relevance of haematocrit and hepatic steatosis

  2006cited by this paper
• Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults.

  2005cited by this paper
• Impact of Body Mass and Body Composition on Circulating Levels of Natriuretic Peptides: Results From the Dallas Heart Study

  2005cited by this paper
• N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease.

  2005cited by this paper
• Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal pro-brain natriuretic peptide concentrations in a large sample of the general population

  2004cited by this paper
• Impact of Obesity on Plasma Natriuretic Peptide Levels

  2004cited by this paper
• Essential biochemistry and physiology of (NT‐pro)BNP

  2004cited by this paper
• NT‐proBNP and the diagnosis of heart failure: a pooled analysis of three European epidemiological studies

  2004cited by this paper
• NT-proBNP and the diagnosis of heart failure: a pooled analysis of three European epidemiological studies.

  2003cited by this paper
• Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis.

  2003cited by this paper
• Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.

  1999cited by this paper
• Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease

  1999cited by this paper
• Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care.

  1997cited by this paper
• Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension.

  1996cited by this paper
• The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators

  1989cited by this paper
• The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.

  1989cited by this paper

• Association between noninvasive hepatic fibrosis indices and heart failure mortality

  2026cites this paper
• Association between liver enzyme levels and prevalence of migraine: the atherosclerosis risk in communities study

  2025cites this paper
• Association of liver related biomarkers with incident cardiovascular disease and all-cause mortality in the Hispanic community health study/study of Latinos (HCHS/SOL), a population-based cohort study

  2025cites this paper
• Pedunculoside targets P2X7R to protect against myocarditis by regulating the NLRP3/PIP2/MAPK signaling pathway

  2025cites this paper
• Coenzyme Q10 alleviates oxidative stress, inflammation and fibrosis via activation of TGFβ1/TNF-α in FCA-Salt hypertensive rats.

  2025cites this paper
• Environmentally responsive changes in mucus indicators and microbiota of Chinese sturgeon Acipenser sinensis.

  2024cites this paper
• Early changes in cardiac troponin T and NT-proBNP levels in neonates receiving ECMO support: a single-center experience

  2024cites this paper
• The clinical value of the Controlling Nutritional Status score for predicting prognosis in systolic heart failure cases in the vulnerable phase

  2023influential citation
• Association Study Between DRD2, DRD3 Genetic Polymorphisms and Adverse Reactions in Chinese Patients on Amisulpride Treatment

  2023cites this paper
• Gender perspective on the association between liver enzyme markers and non-alcoholic fatty liver disease: insights from the general population

  2023cites this paper
• Liver Enzymes and the Risk of Stroke among the General Japanese Population: A Prospective Cohort Study

  2023cites this paper
• Metabolic medicine: The mechanism of metabolic influence on diseases of various systems

  2023cites this paper
• Assessment of hepatic fat content and prediction of myocardial fibrosis in athletes by using proton density fat fraction sequence

  2023cites this paper
• Controlled Release of Therapeutics From Enzyme-Responsive Biomaterials

  2022cites this paper
• High-Sensitivity Cardiac Troponin T in Prediction and Diagnosis of Early Postoperative Hypoxemia after Off-Pump Coronary Artery Bypass Grafting

  2022cites this paper
• DMSO_A_363684 777..778

  2022cites this paper
• Association between non-alcoholic fatty liver disease and risk of incident heart failure: a meta-analysis of observational studies

  2022cites this paper
• Aspartate aminotransferase to alanine aminotransferase ratio and clinical outcomes after acute ischemic stroke: the CNSR-III registry

  2022cites this paper
• Liver Enzymes and Non-Alcoholic Fatty Liver Disease: Important Factors in Assessing Patterns of Clinical Management in Type-2 Diabetes Patients [Letter]

  2022cites this paper
• Ventricular structure and function in non-alcoholic fatty liver disease

  2021cites this paper
• Association between the soluble receptor for advanced glycation end products (sRAGE) and NAFLD in participants in the Atherosclerosis Risk in Communities Study.

  2021cites this paper
• Epigallocatechin-3-Gallate Alleviates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease via Inhibition of Apoptosis and Promotion of Autophagy through the ROS/MAPK Signaling Pathway

  2021cites this paper
• Narrative review of metabolomics in cardiovascular disease

  2021cites this paper
• Cross-Talk Between Non-Alcoholic Fatty Liver Disease and Cardiovascular Disease: Implications for Future Trial Design.

  2021cites this paper
• Наджелудочковые тахикардии у взрослых. Клинические рекомендации 2020

  2021cites this paper
• Elevated gamma-glutamyl transferase has a non-linear association with incident non-alcoholic fatty liver disease in the non-obese Chinese population: a secondary retrospective study

  2021cites this paper
• Association between hemoglobin glycation index and subclinical myocardial injury in the general population free from cardiovascular disease.

  2021cites this paper
• Intermittent Hypoxic Conditioning Alleviates Post-Traumatic Stress Disorder-Induced Damage and Dysfunction of Rat Visceral Organs and Brain

  2020cites this paper
• Sodium acetate prevents nicotine-induced cardiorenal dysmetabolism through uric acid/creatine kinase-dependent pathway.

  2020cites this paper
• Hydrogen Sulfide Attenuates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease by Inhibiting Apoptosis and Promoting Autophagy via Reactive Oxygen Species/Phosphatidylinositol 3-Kinase/AKT/Mammalian Target of Rapamycin Signaling Pathway

  2020cites this paper
• Aspartate aminotransferase and cardiovascular disease—a narrative review

  2020cites this paper
• Glycaemic markers and all-cause mortality in older adults with and without diabetes: the Atherosclerosis Risk in Communities (ARIC) study

  2020cites this paper
• Aspartate aminotransferase and mortality in patients with ischemic heart disease.

  2020cites this paper
• Associations of Cardiac, Kidney, and Diabetes Biomarkers With Peripheral Neuropathy among Older Adults in the Atherosclerosis Risk in Communities (ARIC) Study.

  2020cites this paper
• AST/ALT ratio predicts the functional severity of chronic heart failure with reduced left ventricular ejection fraction

  2020cites this paper
• Liver enzyme variability and risk of heart disease and mortality: A nationwide population‐based study

  2020cites this paper
• High prevalence of non-alcoholic fatty liver disease and metabolic risk factors in Guatemala: A population-based study.

  2019cites this paper
• Metabolomics in early detection and prognosis of acute coronary syndrome.

  2019cites this paper
• Epidemiology and Serum Metabolic Characteristics of Acute Myocardial Infarction Patients in Chest Pain Centers

  2018influential citation
• Natriuretic peptides in the control of lipid metabolism and insulin sensitivity

  2017cites this paper
• Liver Biomarkers in Diabetes mellitus, Prediabetes and Periodontal Disease: Evidence of Triangular Correlation

  2017cites this paper
• The impact of fat distribution on subclinical coronary atherosclerosis in middle-aged Chinese adults.

  2017cites this paper
• Computerized tomography measured liver fat is associated with low levels of N-terminal pro-brain natriuretic protein (NT-proBNP). Multi-Ethnic Study of Atherosclerosis.

  2016cites this paper
• Comprehensive Metabolomic Characterization of Coronary Artery Diseases.

  2016cites this paper
• Gamma glutamyl transferase: A novel cardiovascular outfit for an old liver test

  2016cites this paper
• Opposite associations between alanine aminotransferase and γ-glutamyl transferase levels and all-cause mortality in type 2 diabetes: Analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.

  2016cites this paper
• Low alanine aminotransferase levels and higher number of cardiovascular events in people with Type 2 diabetes: analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study

  2016cites this paper
• S100A1 as a Potential Diagnostic Biomarker for Assessing Cardiotoxicity and Implications for the Chemotherapy of Certain Cancers

  2015cites this paper
• El hígado en enfermedades reumáticas

  2015cites this paper
• Effect of diet/atorvastatin on atherosclerotic lesions associated to nonalcoholic fatty liver disease in chickens.

  2015cites this paper